Public Company News

Yatsen Announces Receipt of NYSE Non-compliance Letter Regarding ADS Trading Price

GUANGZHOU, China, April 12, 2022 /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading Chinese beauty company, today announced that, it has received a letter from the New York Stock Exchange (the "NYSE") datedApril 11, 2022, notifying Yatsen that it is below co...

2022-04-12 19:30 3224

ChipMOS SCHEDULES FIRST QUARTER 2022 FINANCIAL RESULTS CONFERENCE CALL

HSINCHU, April 12, 2022 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange:8150 and NASDAQ: IMOS), an industry leading provider of outsourced semiconductor assembly and test services ("OSAT")...

2022-04-12 18:00 3074

CMG901 for the treatment of gastric cancer and gastroesophageal junction adenocarcinoma was granted the Orphan-drug Designation by the Food and Drug Administration of the United States

CHENGDU, China, April 12, 2022 /PRNewswire/ -- Keymed Biosciences (2162.HK) announced that its new drug candidate CMG901 (the "Claudin 18.2 antibody drug conjugates") for the treatment of gastric cancer and gastroesophageal junction adenocarcinoma has been granted the Orphan-drug Designation by t...

2022-04-12 15:45 1397

/DISREGARD RELEASE: HanAll Biopharma and Daewoong Pharmaceutical/

We are advised by HanAll Biopharma and Daewoong Pharmaceutical that journalists and other readers should disregard the news release, "Daewoong Pharmaceutical and HanAll Biopharma Invest in Turn Biotechnologies to Expand Growth Initiative", issued11-Apr-2022 over PR Newswire. ...

2022-04-12 15:34 2737

Lakeshore Acquisition II Corp. Announces that Ordinary Shares, Rights and Warrants to Commence Separate Trading on or about April 14, 2022

NEW YORK, April 11, 2022 /PRNewswire/ -- Lakeshore Acquisition II Corp. (the "Company") (NASDAQ: LBBBU), a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more busin...

2022-04-12 04:15 2673

Senmiao Technology Announces Ride-Hailing Platform Operating Metrics for March 2022

CHENGDU, China, April 11, 2022 /PRNewswire/ -- Senmiao Technology Limited ("Senmiao" or the "Company") (Nasdaq: AIHS), a financing and servicing company focused on the online ride-hailing industry inChina, as well as an operator of its own online ride-hailing platform, today announced the operati...

2022-04-11 21:00 1282

CBAK Energy to Report Fourth Quarter & Full year 2021 Unaudited Financial Results on Thursday, April 14, 2022

DALIAN, China, April 11, 2022 /PRNewswire/ -- CBAK Energy Technology, Inc. (NASDAQ: CBAT) ("CBAK Energy", or the "Company"), a leading lithium-ion battery manufacturer and electric energy solution provider, today announced that it will report its unaudited financial results for the fourth quarter...

2022-04-11 21:00 1458

NetEase Games Developer Summit 2022 Event Begins on April 18

The NetEase Games Developer Summit 2022 event will be held from April 18-21. The event will bring together industry experts to share their knowledge and insights on a number of exciting video game development topics. GUANGZHOU, China, April 11, 2022 /PRNewswire/ -- NetEase Games, the online game...

2022-04-11 20:00 1918

PharmAbcine Presents Updated Preclinical Data of Its Anti-VISTA Antibody Candidate at AACR 2022

DAEJEON, South Korea, April 11, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), aclinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that the Company presented an updated preclinical data PMC-309, the Company's anti-VISTA ...

2022-04-11 20:00 1719

Weidai Ltd. Announces Full Year 2021 Financial Results

HANGZHOU, China, April 11, 2022 /PRNewswire/ -- Weidai Ltd. ("Weidai" or the "Company") (NYSE: WEI), a leading auto-backed financing solution provider in China, today announced its financial results for the year ended December 31, 2021, which have not been audited or reviewed by the Company's inde...

2022-04-11 19:14 2948

China Automotive Systems Announces Share Repurchase

-  CAAS's board of directors approved a share repurchase program of up to $5 million of its outstanding common shares periodically over the next 12 months - WUHAN, China, April 11, 2022 /PRNewswire/ -- China Automotive Systems, Inc. (Nasdaq: CAAS) ("CAAS" or the "Company"),a leading power steerin...

2022-04-11 18:00 4847

China Online Education Group Announces Management Change

BEIJING, April 11, 2022 /PRNewswire/ -- China Online Education Group ("51Talk" or the "Company") (NYSE: COE), a leading online education platform inChina, with core expertise in English education, announced that Mr. Liming Zhang has tendered his resignation as the Company's Chief Operating Office...

2022-04-11 17:00 1653

TRICORBRAUN TO ACQUIRE PB PACKAGING, EXPANDING ITS PRESENCE IN AUSTRALIA

ST. LOUIS, April 11, 2022 /PRNewswire/ -- Global packaging leader TricorBraun announced today that it has entered into an agreement to acquire PB Packaging ("PB"), a wholly-owned business of Pro-Pac Packaging Limited (ASX: PPG) ("Pro-Pac"), expanding its presence inAustralia. One of Australia's ...

2022-04-11 07:01 1690

Zhihu Inc. Launches Global Offering

BEIJING, April 8, 2022 /PRNewswire/ -- Zhihu Inc. (NYSE: ZH) ("Zhihu" or the "Company"), the operator of Zhihu, a leading online content community inChina, today announced the launch of its global offering (the "Global Offering") of 26,000,000 Class A ordinary shares of the Company, which compris...

2022-04-09 04:56 6856

Gracell Biotechnologies to Present Data at AACR Annual Meeting 2022 Showcasing Early First-in-Human Results for GC502 in r/r B-ALL

Allogeneic, off-the-shelf CAR-T therapy with CD19/CD7 dual-directed CAR shows promising early results in patients with r/r B-ALL PALO ALTO, Calif. and SUZHOU, China, April 8, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage bio...

2022-04-09 04:00 4296

Samyang Foods sponsors BTS PERMISSION TO DANCE ON STAGE - LAS VEGAS

- Part of global promotion campaign of K-spicy to commemorate the 10th anniversary of the launching Buldak SEOUL, South Korea, April 8, 2022 /PRNewswire/ -- Samyang Foods announced on April 8 that it will participate as the main sponsor of BTS PERMISSION TO DANCE ON STAGE –LAS VEGAS, commemorati...

2022-04-09 00:00 4664

KAZIA THERAPEUTICS ANNOUNCES PRECLINICAL DATA PRESENTED AT AACR CONFERENCE BY JOHNS HOPKINS UNIVERSITY SHOWING ACTIVITY OF PAXALISIB IN PAEDIATRIC BRAIN TUMOURS

SYDNEY, April 8, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce new preclinical data demonstrating the activity of paxalisib in two forms of childhood brain cancer with very high unmet medical need. ...

2022-04-08 20:30 4208

Zhihu Inc. Files Its Annual Report on Form 20-F

BEIJING, April 8, 2022 /PRNewswire/ -- Zhihu Inc. ("Zhihu" or the "Company") (NYSE: ZH), the operator of Zhihu, a leading online content community inChina, today announced that it filed its annual report on Form 20-F for the fiscal year endedDecember 31, 2021 with the Securities and Exchange Comm...

2022-04-08 20:16 6183

OliX Pharmaceuticals Identifies Inhibition of Target Gene Expression in Nonhuman Primate Models for NASH Candidate

* Identified knockdown of target genes for the NASH treatment candidate * Reduction of ALT and AST liver marker levels observed in monkey models * Company to present results at the 2022 Academic Symposium of the Korean Endocrine Society SUWON, South Korea, April 8, 2022 /PRNewswire/ -- OliX ...

2022-04-08 20:00 3768

TWO ABSTRACTS AT AACR CONFERENCE PRESENT DETAILED STUDY DESIGN AND INNOVATIVE BIOMARKER STRATEGY FOR ONGOING PHASE I STUDY OF EVT801 IN ADVANCED CANCER

SYDNEY, April 8, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), a late stage, oncology-focused drug development company, is pleased to announce two presentations detailing the ongoing phase I study of the company's investigational novel drug, EVT801, a selective VEGFR3 ...

2022-04-08 20:00 3978
1 ... 657658659660661662663 ... 752